CA45422-2A - 0x00000000000067A3
Healthy Males & Females
Alchemy
* Stipend may pay up to reflected amount.
Start Date:
October 1, 2025 - 1:30pm
End Date:
January 15, 2026 - 7:00am
Study Details
Study Number: CA45422
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $8,750.00
Study Criteria
Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs
Study Information
Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 23
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 5 Returns & 1 Phone Call
Screening Dates:
Event Day | Event Date |
---|---|
Wednesday | 9/24/2025 |
Tuesday | 9/30/2025 |
Doctor Exam Dates:
Event Day | Event Date |
---|---|
Wednesday | 9/24/2025 |
Tuesday | 9/30/2025 |
Study Dates:
Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
---|---|---|---|---|---|---|
Check-In | Wednesday | 10/1/2025 1:30:00 PM | Sunday | 10/5/2025 8:00:00 AM | 1 | Lincoln |
Phone participant | Thursday | 10/9/2025 11:00:00 AM | 1 | Lincoln | ||
Return | Thursday | 10/16/2025 7:00:00 AM | Thursday | 10/16/2025 8:00:00 AM | 1 | Lincoln |
Return | Thursday | 10/30/2025 7:00:00 AM | Thursday | 10/30/2025 8:00:00 AM | 1 | Lincoln |
Return | Wednesday | 11/26/2025 6:00:00 AM | Wednesday | 11/26/2025 7:00:00 AM | 1 | Lincoln |
Return | Thursday | 12/18/2025 6:00:00 AM | Thursday | 12/18/2025 7:00:00 AM | 1 | Lincoln |
Return | Thursday | 1/15/2026 6:00:00 AM | Thursday | 1/15/2026 7:00:00 AM | 1 | Lincoln |